2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Caves: new trials by email Literature Review of Caves trials Research Report on Caves
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma LMB-100, ipilimumab, Diphenhydramine - Mesothelioma | Phase 1 | Terminated | National Cancer Institute (NCI) | 2 | 2021-06-11 | 2024-02-02 |
| Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer EP0057, olaparib, CT scan - Urothelial Carcinoma, Urothelial Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 45 | 2016-05-09 | 2026-08-13 |
Carcinoma, Transitional Cell (1) · Lung Neoplasms (1) · Mesothelioma (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1)
National Cancer Institute (NCI) (2)
United States (2)
Anish Thomas, M.D. (1) · Raffit Hassan, M.D. (1)